BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nicardipine Hydrochloride

A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.

94+ PubMed studies analyzed · 9 RCTs · Evidence Score: 46.5

Research Domains

Nicardipine Hydrochloride has been studied across 17 research domains including ❤️ Cardiovascular, 🦴 Bone & Joint, ✨ Skin & Hair, 🧠 Focus & Attention, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 39% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nicardipine Hydrochloride, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Bisphenol
19 shared targets
Promethazine
22 shared targets
17
19 shared targets
Toxaphene
18 shared targets
Methyltestosterone
16 shared targets
Phenelzine
17 shared targets
Budesonide
18 shared targets
Testosterone
18 shared targets
Lynestrenol
17 shared targets
trequinsin
17 shared targets
Loading evidence profile...

This evidence profile for Nicardipine Hydrochloride is generated deterministically from 94 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.